KCT0000509
Recruiting
未知
Identification of therapeutic target and disease specific marker of atopic dermatitis using proteomic analysis for tissue and blood
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the skin and subcutaneous tissue
- Sponsor
- Keimyung University
- Enrollment
- 31
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •actue atopic dermatitis
- •age 15 \- 40
- •actue aggrevated atopic dermatitis
Exclusion Criteria
- •skin biopsy impossible due to physical cosmetic problems
- •age below 15 and old age
- •physically impaired person
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
ovel therapeutic targets and biomarkers in patients with Systemic Lupus ErythematosusSLEsystemic lupus erythematosus10003816NL-OMON35524niversitair Medisch Centrum Utrecht62
Withdrawn
Not Applicable
A search for novel therapeutic targets and biomarkers in patients with Systemic Lupus ErythematosusSLEsystemic lupus erythematosus10003816NL-OMON36575niversitair Medisch Centrum Utrecht75
Recruiting
Not Applicable
Pharmacokinetic and pharmacodynamic target attainment of amoxicillin(-clavulanic acid) in pleural empyema fluid and complicated parapneumonic effusiopleural effusionPus in the area between the lungs10004018NL-OMON49528Academisch Medisch Centrum20
Completed
Not Applicable
Pharmacokinetic and pharmacodynamic target attainment of ceftazidime in adult patients on general wards with different degrees of renal function: a prospective observational cohort studyInfectionsRenal impairment1000401810038430NL-OMON50052Academisch Medisch Centrum40
Active, not recruiting
Phase 1
Target attainment of the antibiotic cefuroxime for the treatment of hospital acquired infections.Bacterial infectionsTherapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]EUCTR2021-006860-26-NLoordwest Ziekenhuisgroep45